Opportunity ID: 324836

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-20-118
Funding Opportunity Title: National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U01 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.242 — Mental Health Research Grants
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Feb 25, 2020
Last Updated Date: Feb 25, 2020
Original Closing Date for Applications: Mar 25, 2022
Current Closing Date for Applications: Mar 25, 2022
Archive Date: Apr 30, 2022
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Independent school districts
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
County governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
State governments
City or township governments
Special district governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement is to accelerate innovative drug and device therapies translation from discovery to early human studies. Studies responsive to this FOA will develop pharmacologic and neuromodulatory tools for basic and clinical research on mental health disorders, substance use disorders (SUDs) or alcohol addiction; develop and validate tools (pharmacologic or neurostimulation) in support of experimental therapeutic studies of innovative new candidates for mental disorders; and support early-stage human studies to rapidly assess the safety, tolerability, and pharmacodynamics of promising drug candidates/devices and new indications for novel Investigational New Drug (IND)-ready agents or Investigational Device Exemption (IDE)-ready devices for the treatment of mental disorders, SUDs or alcohol addiction.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-20-118.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Folder 324836 Full Announcement-PAR-20-118 -> PAR-20-118-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F DO NOT USE PKG00258825 Jun 27, 2020 Oct 10, 2020 View
FORMS-F-REVISED Use for due dates on or before January 24, 2022 PKG00263710 Oct 10, 2020 Jan 24, 2022 View
FORMS-G Use for due dates on or after January 25, 2022 PKG00270396 Nov 18, 2021 Mar 25, 2022 View

Package 1

Mandatory forms

324836 RR_SF424_2_0-2.0.pdf

324836 PerformanceSite_2_0-2.0.pdf

324836 RR_OtherProjectInfo_1_4-1.4.pdf

324836 RR_KeyPersonExpanded_2_0-2.0.pdf

324836 PHS398_CoverPageSupplement_4_0-4.0.pdf

324836 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

324836 RR_Budget_1_4-1.4.pdf

324836 RR_SubawardBudget30_1_4-1.4.pdf

324836 PHS398_ModularBudget_1_2-1.2.pdf

324836 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

324836 RR_SF424_2_0-2.0.pdf

324836 PHS398_CoverPageSupplement_5_0-5.0.pdf

324836 RR_OtherProjectInfo_1_4-1.4.pdf

324836 PerformanceSite_2_0-2.0.pdf

324836 RR_KeyPersonExpanded_2_0-2.0.pdf

324836 PHS398_ResearchPlan_4_0-4.0.pdf

324836 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

324836 RR_Budget_1_4-1.4.pdf

324836 RR_SubawardBudget30_1_4-1.4.pdf

324836 PHS398_ModularBudget_1_2-1.2.pdf

324836 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

324836 RR_SF424_5_0-5.0.pdf

324836 PHS398_CoverPageSupplement_5_0-5.0.pdf

324836 RR_OtherProjectInfo_1_4-1.4.pdf

324836 PerformanceSite_4_0-4.0.pdf

324836 RR_KeyPersonExpanded_4_0-4.0.pdf

324836 PHS398_ResearchPlan_4_0-4.0.pdf

324836 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

324836 RR_Budget_3_0-3.0.pdf

324836 RR_SubawardBudget30_3_0-3.0.pdf

324836 PHS398_ModularBudget_1_2-1.2.pdf

324836 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T14:11:28-05:00

Share This Post, Choose Your Platform!

About the Author: